Neomycin/Polymyxin B/ Bacitracin/Lidocaine

Neomycin/Polymyxin B/ Bacitracin/Lidocaine

DEA Class;  OTC

Common Brand Names; Lanabiotic Ointment

  • Anesthetics, Topical; 

Neomycin, polymyxin B, and bacitracin elicit bacteriostatic activity

Lidocaine provides local anesthetic effect

Indicated for Skin Infection Prevention

Hypersensitivity

Allergic contact dermatitis

Ototoxicity and nephrotoxicity possible if treating large surface area or chronic use

Lidocaine may be significantly absorbed from mucosal surfaces and open wounds

Pregnancy category: C

Lactation: unknown if neomycin, polymyxin B, or bacitracin excreted in breast milk; systemic absorption of topical lidocaine has been reported

Pregnant or breastfeeding patients should seek advice of health professional before using OTC drugs

Adults

Skin Disorders

Apply q8-12hr

Hemorrhoids, Anal fissures, Pruritus ani

Apply BID to areas of discomfort and anal opening

Pediatric

Safety and efficacy not established

neomycin/polymyxin B/bacitracin/lidocaine

topical ointment

  • (3.5mg/10,000units/500units/40mg)/g
DrugsAce
Logo